Navigation Links
FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
Date:5/5/2010

The use of combined positron emission tomography and computed tomography (PET/CT) can confirm a suspected colorectal cancer recurrence at an early stage, helping significantly in treatment planning and improved targeted patient care, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA. PET/CT is a type of nuclear medicine imaging that uses traces of radioactive material to diagnose or treat many types of cancers.

Colorectal cancer is the fourth most common cancer in the United States and the second most common in Europe. "With modern surgical techniques and advanced chemotherapy, growing subsets of patients with colorectal cancer recurrences are being considered for treatment with curative intent. Therefore, accurate re-staging and early detection of recurrence is important," said Rohit Kochhar, MD, lead author of the study.

The study, performed at The Christie NHS Foundation Trust in Manchester, United Kingdom, included 71 patients with suspected colorectal recurrence. Fifty-one patients had a suspected local recurrence based upon conventional CT or MR and 20 patients had a suspected recurrence based upon a carcinoembryonic antigen (CEA) test with unremarkable conventional imaging.

All 71 patients underwent a PET/CT scan to confirm/disconfirm recurrence. "PET/CT accurately confirmed a recurrence in 40/71 patients. This shows that PET/CT has a definite role in the management of patients with recurrent colorectal cancer in addition to conventional imaging and the CEA test," said Kochhar.


'/>"/>

Contact: Heather Curry
hcurry@acr-arrs.org
703-390-9822
American College of Radiology / American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Protein plays a critical role in the development of aggressive breast cancer
2. Sisters of Bon Secours Plays Active Role in Bringing Healthcare to Regions of Peru
3. Breakthrough design opens door to full screen Braille displays for the blind
4. Poorly understood cell plays role in immunity against the flu
5. Visual Processing Plays Role in Body Dysmorphic Disorder
6. Amerigroup Plays Key Role in Fraud Conviction
7. Playground Surface Plays a Role in Kids Injuries
8. Study: Mechanomyography to be accurate in detecting nerves during minimally invasive spine surgery
9. Researchers discover novel method for detecting MIRCERA
10. Investigators examine colorectal cancer screening methods among diverse populations
11. Researchers show that nitric oxide-donating naproxen can boost colorectal cancer prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... combining seaweeds, botanicals and 100 percent pure essential oils, announced the company had a ... Head, SC. , The annual ECRM event gives companies that work in the nutritional, ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... ... Angel”: a heartwarming and earnest tale of faith and believing in the path ... the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of The ... of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, but ...
(Date:1/20/2017)... ... 2017 , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true ... mother of three in Oklahoma City, and a devoted woman of faith. , “Becoming ... been in the back of my mind for years, but actually doing it might have ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Management System: an On-demand E-learning system for Clinical and Regulatory education for ... is based on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Jan. 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ... mitochondrial dysfunction, today announced new additions to its senior ... Chief Medical Officer, and Daniel Geffken as ... Jim Carr , Pharm.D. has been promoted to ... pleased to welcome Doug and Daniel to our management ...
(Date:1/19/2017)... CITY, Calif. , Jan. 19, 2017  Abaxis, ... company manufacturing point-of-care blood analysis instruments and consumables for ... conference call to discuss its financial results for the ... The call will be at 4:15 p.m. ET on ... results for the third quarter fiscal year 2017 after ...
(Date:1/19/2017)... LEXINGTON, Massachusetts , January 19, 2017 ... SHPG ) announced that the U.S. Food and Drug ... resubmission of a New Drug Application (NDA) for SHP465, ... being evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity ... decision on or around June 20, 2017, the designated ...
Breaking Medicine Technology: